Global barriers to accessing off-patent endocrine therapies: a renaissance of the orphan disease?
Nipun Lakshitha de SilvaHarsha DissanayakeSanjay KalraKarim MeeranNoel P SomasundaramChanna N JayasenaPublished in: The Journal of clinical endocrinology and metabolism (2023)
Lack of availability and disproportionate price inflation affecting essential off-patent endocrine therapies is common due to several interrelated factors. Global collaboration among healthcare organisations with the support of policy-making bodies might be needed to mitigate this.